These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32379426)

  • 1. Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor.
    Reshitko GS; Yamansarov EY; Evteev SA; Lopatukhina EV; Shkil' DO; Saltykova IV; Lopukhov AV; Kovalev SV; Lobov AN; Kislyakov IV; Burenina OY; Klyachko NL; Garanina AS; Dontsova OA; Ivanenkov YA; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Bioconjug Chem; 2020 May; 31(5):1313-1319. PubMed ID: 32379426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
    Petrov RA; Mefedova SR; Yamansarov EY; Maklakova SY; Grishin DA; Lopatukhina EV; Burenina OY; Lopukhov AV; Kovalev SV; Timchenko YV; Ondar EE; Ivanenkov YA; Evteev SA; Vaneev AN; Timoshenko RV; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Mol Pharm; 2021 Jan; 18(1):461-468. PubMed ID: 33264010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
    Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
    Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R).
    Stokmaier D; Khorev O; Cutting B; Born R; Ricklin D; Ernst TO; Böni F; Schwingruber K; Gentner M; Wittwer M; Spreafico M; Vedani A; Rabbani S; Schwardt O; Ernst B
    Bioorg Med Chem; 2009 Oct; 17(20):7254-64. PubMed ID: 19762243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
    D'Souza AA; Devarajan PV
    J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor.
    Huang X; Leroux JC; Castagner B
    Bioconjug Chem; 2017 Feb; 28(2):283-295. PubMed ID: 27966887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
    Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma.
    Yamansarov EY; Lopatukhina EV; Evteev SA; Skvortsov DA; Lopukhov AV; Kovalev SV; Vaneev AN; Shkil' DO; Akasov RA; Lobov AN; Naumenko VA; Pavlova EN; Ryabaya OO; Burenina OY; Ivanenkov YA; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Bioconjug Chem; 2021 Apr; 32(4):763-781. PubMed ID: 33691403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Small-Molecule ASGP-R Ligands.
    Majouga AG; Ivanenkov YA; Veselov MS; Lopuhov AV; Maklakova SV; Beloglazkina EK; Binevski PV; Klyachko NL; Sandulenko YB; Galkina NY; Koteliansky VE
    Curr Drug Deliv; 2016; 13(8):1303-1312. PubMed ID: 27440073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel derivatives of arabinogalactan, pullulan & lactobionic acid for targeting asialoglycoprotein receptor: Biomolecular interaction, synthesis & evaluation.
    Warrier DU; Dhanabalan AK; Krishnasamy G; Kolge H; Ghormade V; Gupta CR; Ambre PK; Shinde UA
    Int J Biol Macromol; 2022 May; 207():683-699. PubMed ID: 35248606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
    Sakashita M; Mochizuki S; Sakurai K
    Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-d-galactosamine/asialoglycoprotein receptor pathway.
    Sato Y; Kinami Y; Hashiba K; Harashima H
    J Control Release; 2020 Jun; 322():217-226. PubMed ID: 32145269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting
    Nie H; Qiu B; Yang QX; Zhao Y; Liu XM; Zhang YT; Liao FL; Zhang SY
    J Liposome Res; 2021 Mar; 31(1):79-89. PubMed ID: 31691619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
    Nie H; Liu XM; Yang QX; Luo XD; Zhao Y; Zhang SY
    Int J Pharm; 2022 Aug; 624():121967. PubMed ID: 35777585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.
    Yang D; Zheng X; Wang N; Fan S; Yang Y; Lu Y; Chen Q; Liu X; Zheng J
    Oncotarget; 2016 Sep; 7(36):57498-57513. PubMed ID: 27542278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor.
    Sanhueza CA; Baksh MM; Thuma B; Roy MD; Dutta S; Préville C; Chrunyk BA; Beaumont K; Dullea R; Ammirati M; Liu S; Gebhard D; Finley JE; Salatto CT; King-Ahmad A; Stock I; Atkinson K; Reidich B; Lin W; Kumar R; Tu M; Menhaji-Klotz E; Price DA; Liras S; Finn MG; Mascitti V
    J Am Chem Soc; 2017 Mar; 139(9):3528-3536. PubMed ID: 28230359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
    Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
    Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs.
    Hu J; Liu J; Yang D; Lu M; Yin J
    Protein Pept Lett; 2014; 21(10):1025-30. PubMed ID: 24975671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
    Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
    MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles.
    D'Souza AA; Jain P; Galdhar CN; Samad A; Degani MS; Devarajan PV
    AAPS J; 2013 Jul; 15(3):696-706. PubMed ID: 23580183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.